Masimo Corporation

NASDAQ:MASI

Medical - Devices

Healthcare
$179.95 +0.00%

+$0.00 today

Market cap
$9.42B
Beta
1.10
P/E (TTM)
123.1
EPS (TTM)
$1.46
52W Low $125.94High $179.99

Volume 0.00M

Average 1.08M

MASI Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

Masimo CorporationNASDAQ: MASI

Income Tax Expense · Q1 FY2026 · quarter ended Apr 2026

Income tax expense dips below year-ago levels

Q1 FY2026 income tax expense of $15M fell 29.2% year over year, behind the +247.9% change in trailing-twelve-month income tax expense. Sequentially, it rose 24.0% from the prior quarter. Over 3 fiscal years it compounded at +9.2% a year.

Context

  • Income tax expense amounted to 4.3% of revenue in FY2025, up 4.2 pp from a year earlier.
  • Income tax expense increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -29.2% toward the trailing-twelve-month pace of +247.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterApr 2026
$15M+24.0% QoQ
Last fiscal yearJan 2026
$64.9M+16325.0% YoY
LTMApr 2026
$58.8M+247.9% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-29.2%——
1 year+16325.0%——
3-year CAGR+9.2%——
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
64.9M USD
Year-over-year change
+16325.0%
4-year CAGR
+9.7%

Income Tax Expense vs competitors

How MASI compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +247.9% is the 4th highest of 10, against a peer median of +2.3%.
  • Income tax expense amounts to 3.8% of revenue for MASI, versus a peer median of 1.6%.
MASI Competitors
Income Tax Expense for MASI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BAXBaxter International Inc.LTM Jun 2026$485M USD+698.8%—4.2%
HSICHenry Schein, Inc.LTM Jun 2026$132M USD+2.3%-9.5%1.0%
BIOBio-Rad Laboratories, Inc.LTM Jun 2026$128M USD-2.3%—4.9%
AVTRAvantor, Inc.LTM Jun 2026$106M USD-23.6%-18.6%1.6%
ATRAptarGroup, Inc.LTM Jun 2026$91.59M USD-10.0%+1.3%2.3%
MASIMasimo CorporationLTM Apr 2026$58.8M USD+247.9%+9.2%3.8%
STVNStevanato Group S.p.A.LTM Jun 2026€57.41M EUR+27.3%+2.0%4.7%
RGENRepligen CorporationLTM Jun 2026$10.61M USD+4553.9%-25.9%1.4%
MOHMolina Healthcare, Inc.LTM Sep 2026$7M USD-97.4%-24.4%0.0%
ABVXAbivax S.A.FY2025€5.85M EUR———
RYTMRhythm Pharmaceuticals, Inc.LTM Sep 2026$1.57M USD+258.0%—0.6%
Peer median (excluding MASI) —+2.3%-14.0%1.6%

Competitors are the stored peer set for MASI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Revenue1.24B2.04B2.05B2.09B1.53B
Cost of Revenue430.8M977M1.04B1.09B581.7M
Gross Profit808.4M1.06B1B1B945.2M
Gross Margin65.2%52.0%49.0%48.0%61.9%
Research & Development137.2M191.4M175.2M222.8M126.4M
Selling, General & Admin395.4M657.4M664M743.8M506M
Operating Expenses532.6M848.8M867M1.27B632.4M
Depreciation & Amortization35.6M136.1M98.3M103M38.8M
EBITDA310.3M355.2M236.7M(158.7M)344.6M
EBITDA Margin25.0%17.4%11.6%-7.6%22.6%
Operating Income275.8M210M136.5M(266.7M)312.8M
Operating Margin22.3%10.3%6.7%-12.7%20.5%
Interest Income900K1.8M3M4.8M3.4M
Interest Expense300K25.7M50.3M43.6M33.2M
Other Income / Expenses(1.4M)(16.6M)(48.4M)(38.6M)(40.2M)
Income Before Tax274.4M193.4M88.1M(305.3M)272.6M
Pre-Tax Margin22.1%9.5%4.3%-14.6%17.9%
Income Tax Expense44.8M49.9M6.6M(400K)64.9M
Net Income229.6M143.5M81.5M(304.9M)(151.5M)
Net Margin18.5%7.0%4.0%-14.6%-9.9%
EPS (Basic)4.162.681.54(5.72)(2.83)
EPS (Diluted)3.982.601.51(5.72)(2.80)
Weighted Avg Shares55.17M53.6M52.8M53.3M53.6M
Weighted Avg Shares (Diluted)57.68M55.2M54.1M53.3M54.2M

Masimo Corporation

NASDAQ:MASI

Intrinsic Alpha fair value

Locked

Current Price

$179.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.